Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-CAG in relapsed/refractory AML
NCT03181815Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cladribine in acute myeloid leukemia (AML), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
cladribine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03181815.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03181815.